QQQ   282.16 (-0.91%)
AAPL   113.88 (-1.01%)
MSFT   214.50 (-0.80%)
FB   283.58 (-0.42%)
GOOGL   1,617.41 (-0.95%)
AMZN   3,191.99 (-0.39%)
TSLA   414.11 (-1.55%)
NVDA   537.15 (-1.19%)
BABA   309.96 (+0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.38 (+0.51%)
T   27.58 (-0.86%)
F   8.06 (-1.23%)
ACB   4.68 (+0.00%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.60 (-2.06%)
BA   164.75 (-1.56%)
DIS   126.20 (-1.68%)
QQQ   282.16 (-0.91%)
AAPL   113.88 (-1.01%)
MSFT   214.50 (-0.80%)
FB   283.58 (-0.42%)
GOOGL   1,617.41 (-0.95%)
AMZN   3,191.99 (-0.39%)
TSLA   414.11 (-1.55%)
NVDA   537.15 (-1.19%)
BABA   309.96 (+0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.38 (+0.51%)
T   27.58 (-0.86%)
F   8.06 (-1.23%)
ACB   4.68 (+0.00%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.60 (-2.06%)
BA   164.75 (-1.56%)
DIS   126.20 (-1.68%)
QQQ   282.16 (-0.91%)
AAPL   113.88 (-1.01%)
MSFT   214.50 (-0.80%)
FB   283.58 (-0.42%)
GOOGL   1,617.41 (-0.95%)
AMZN   3,191.99 (-0.39%)
TSLA   414.11 (-1.55%)
NVDA   537.15 (-1.19%)
BABA   309.96 (+0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.38 (+0.51%)
T   27.58 (-0.86%)
F   8.06 (-1.23%)
ACB   4.68 (+0.00%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.60 (-2.06%)
BA   164.75 (-1.56%)
DIS   126.20 (-1.68%)
QQQ   282.16 (-0.91%)
AAPL   113.88 (-1.01%)
MSFT   214.50 (-0.80%)
FB   283.58 (-0.42%)
GOOGL   1,617.41 (-0.95%)
AMZN   3,191.99 (-0.39%)
TSLA   414.11 (-1.55%)
NVDA   537.15 (-1.19%)
BABA   309.96 (+0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.38 (+0.51%)
T   27.58 (-0.86%)
F   8.06 (-1.23%)
ACB   4.68 (+0.00%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.60 (-2.06%)
BA   164.75 (-1.56%)
DIS   126.20 (-1.68%)
Log in
ASX:IPD

ImpediMed Limited (IPD.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.04
MA: A$0.04
A$0.04
52-Week Range N/A
Volume1.62 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.10 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 7 3860 3700
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.74 million
Book ValueA$0.03 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive IPD News and Ratings via Email

Sign-up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ImpediMed Limited (IPD.AX) (ASX:IPD) Frequently Asked Questions

When is ImpediMed Limited (IPD.AX)'s next earnings date?

ImpediMed Limited (IPD.AX) is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020.
View our earnings forecast for ImpediMed Limited (IPD.AX)
.

Who are some of ImpediMed Limited (IPD.AX)'s key competitors?

What other stocks do shareholders of ImpediMed Limited (IPD.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ImpediMed Limited (IPD.AX) investors own include Bardoc Gold Limited (BDC.AX) (BDC) and Appen (APX).

Who are ImpediMed Limited (IPD.AX)'s key executives?

ImpediMed Limited (IPD.AX)'s management team includes the following people:
  • Mr. Richard Carreon, MD, CEO, Pres & Exec. Director
  • Mr. David Michae Adams B.Sc., J.D., BSc, Sr. VP of Operations & Strategic Planning
  • Mr. Shashi Tripathi, Chief Technology Officer
  • Mr. Dennis Schlaht, Sr. VP of R&D and Technology
  • Ms. Catherine Kingsford, Sr. VP of Medical Affairs
  • Mr. Timothy Cruickshank, Chief Financial Officer
  • Mr. Michael Bassett, Sr. VP of Corp. & Strategic Devel.
  • Ms. Nancy T. Deisinger, VP of HR
  • Dr. Frank A. Vicini, Chief Medical Officer
  • Ms. Leanne Ralph A.C.I.S., BBus, ACIS, AAICD, Company Sec.

What is ImpediMed Limited (IPD.AX)'s stock symbol?

ImpediMed Limited (IPD.AX) trades on the ASX under the ticker symbol "IPD."

How big of a company is ImpediMed Limited (IPD.AX)?

ImpediMed Limited (IPD.AX) has a market capitalization of $0.00 and generates $5.74 million in revenue each year. ImpediMed Limited (IPD.AX) employs 69 workers across the globe.

What is ImpediMed Limited (IPD.AX)'s official website?

The official website for ImpediMed Limited (IPD.AX) is www.impedimed.com.

How can I contact ImpediMed Limited (IPD.AX)?

The company can be reached via phone at 61 7 3860 3700.

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.